Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (49)

2024

  1. Reactive antibodies against brain antigens as serological biomarkers of neurodegenerative diseases

    Advanced Neurology, Vol. 3, Núm. 1

  2. Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2023

  1. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment

    International Review of Neurobiology (Academic Press Inc.), pp. 103-143

  2. Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  3. Sexual differences in locus coeruleus neurons and related behavior in C57BL/6J mice

    Biology of Sex Differences, Vol. 14, Núm. 1

  4. Targeting parvalbumin-expressing neurons in the substantia nigra pars reticulata restores motor function in parkinsonian mice

    Cell Reports, Vol. 42, Núm. 10

2022

  1. Dopamine D4 receptor is a regulator of morphine-induced plasticity in the rat dorsal striatum

    Cells, Vol. 11, Núm. 1

  2. Identification of potentially irritating intravenous medications

    Enfermeria Intensiva, Vol. 33, Núm. 3, pp. 132-140

  3. Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation

    Frontiers in Pharmacology, Vol. 13

2021

  1. Study of tissue-specific reactive oxygen species formation by cell membrane microarrays for the characterization of bioactive compounds

    Membranes, Vol. 11, Núm. 12

  2. The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats

    British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532

  3. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2020

  1. 6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata

    British Journal of Pharmacology, Vol. 177, Núm. 17, pp. 3957-3974

  2. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers

    Frontiers in Neuroscience, Vol. 14

  3. Current Techniques for Investigating the Brain Extracellular Space

    Frontiers in Neuroscience, Vol. 14

  4. Editorial: Non-Dopaminergic Systems in Parkinson’s Disease

    Frontiers in Pharmacology

  5. The Noradrenergic System in Parkinson’s Disease

    Frontiers in Pharmacology, Vol. 11

2019

  1. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats

    Experimental Neurology, Vol. 322

  2. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum

    Cells, Vol. 8, Núm. 9

  3. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia

    International Review of Neurobiology (Academic Press Inc.), pp. 259-279